Two years later, the same group of researchers uncovered that miR-193b could also target platelet-derived growth factor receptor beta (PDGFRβ), suppressor of mothers against Decapentaplegic 4 (SMAD4), and yes-associated protein 1 (YAP1) to decrease liposarcoma cell growth and viability and induce adipogenic differentiation (Fig. 1, Fig. 2c) [30]. The gene discussed is SMAD4; the disease is liposarcoma.